CAS 404828-08-6

4-Quinazolinamine,5,6,7,8-tetrahydro-N-(5-methyl-1H-pyrazol-3-yl)-2-phenyl-

Description:

4-Quinazolinamine, 5,6,7,8-tetrahydro-N-(5-methyl-1H-pyrazol-3-yl)-2-phenyl- is a chemical compound characterized by its complex structure, which includes a quinazolinamine core fused with a tetrahydro moiety and substituted with a phenyl group and a 5-methyl-1H-pyrazol-3-yl group. This compound typically exhibits properties associated with heterocyclic compounds, including potential biological activity due to the presence of nitrogen-containing rings. It may demonstrate solubility in organic solvents and varying degrees of stability depending on environmental conditions. The presence of multiple functional groups suggests potential for interactions with biological targets, making it of interest in medicinal chemistry. Additionally, its molecular structure may influence its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME). As with many compounds in this class, further studies would be necessary to elucidate its specific reactivity, potential applications, and safety profile in various contexts.

Formula: C₁₈H₁₉N₅

Synonyms:

• (5-Methyl-2H-pyrazol-3-yl)(2-phenyl-5,6,7,8-tetrahydroquinazolin-4-yl)amine

GSK3i XIII

CAS: 404828-08-6

GSK3i XIII

Purity: ≥98%

Molecular weight: 305.38g/mol

Ref: 54-BUP07294

GSK3i XIII

CAS: 404828-08-6

GSK3i XIII (GSK3 inhibitor XIII) is a GSK-3 ATP-binding site inhibitor.

Formula: C₁₈H₁₉N₅

Purity: 98.87%

Color and Shape: Solid

Molecular weight: 305.38

Ref: TM-T24111